168 related articles for article (PubMed ID: 32274326)
1. Corrigendum to: ``The immune landscape of chondrosarcoma reveals an immunosuppressive environment in the dedifferentiated subtypes and exposes CSFR1+ macrophages as a promising therapeutic target.'' J Bone Oncol. 2020 Feb; 20: 100271.
Richert I; Gomez-Brouchet A; Bouvier C; Du Bouexic De Pinieux G; KaranianM A; Blay JY; Dutour A
J Bone Oncol; 2020 Jun; 22():100287. PubMed ID: 32274326
[TBL] [Abstract][Full Text] [Related]
2. The immune landscape of chondrosarcoma reveals an immunosuppressive environment in the dedifferentiated subtypes and exposes CSFR1+ macrophages as a promising therapeutic target.
Iseulys R; Anne GB; Corinne B; Gonzague DBP; Marie K; Jean-Yves B; Aurélie D
J Bone Oncol; 2020 Feb; 20():100271. PubMed ID: 31956474
[TBL] [Abstract][Full Text] [Related]
3. Erratum to "Identifying biomolecules and constructing a prognostic risk prediction model for recurrence in osteosarcoma" [J. Bone Oncol. 26 (2021) 100331].
Zhang M; Liu Y; Kong D
J Bone Oncol; 2021 Aug; 29():100371. PubMed ID: 34159051
[TBL] [Abstract][Full Text] [Related]
4. Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets.
van Oosterwijk JG; Meijer D; van Ruler MA; van den Akker BE; Oosting J; Krenács T; Picci P; Flanagan AM; Liegl-Atzwanger B; Leithner A; Athanasou N; Daugaard S; Hogendoorn PC; Bovée JV
Am J Pathol; 2013 Apr; 182(4):1347-56. PubMed ID: 23415961
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum to "Why should radiation oncology do translational research?" [Rep Pract Oncol Radiother 2019;24(1):60-64].
Cañas R; Linares I; Guedea F; Berenguer Francés MÁ
Rep Pract Oncol Radiother; 2019; 24(2):151. PubMed ID: 30723386
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein: An independent predictor for dedifferentiated chondrosarcoma.
Nemecek E; Funovics PT; Hobusch GM; Lang S; Willegger M; Sevelda F; Brodowicz T; Stihsen C; Windhager R; Panotopoulos J
J Orthop Res; 2018 Oct; 36(10):2797-2801. PubMed ID: 29701260
[TBL] [Abstract][Full Text] [Related]
7. A case of dedifferentiated chondrosarcoma arising in the cricoid cartilage that mimicked an aneurysmal bone cyst.
Chen L; Yu Z; Jiang R; Dong P; Shen B; Li Y
Postgrad Med; 2018 Mar; 130(2):274-277. PubMed ID: 29160138
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum to "Knowledge of Opioid-induced Respiratory Depression Among Chinese Healthcare Professionals：A Cross-Sectional Study" [Asia-Pacific J Oncol Nursing 9 (2022) 55-60].
Li X; Li N; Lu Y; Ma X; Yang H; Sun H; Chen F
Asia Pac J Oncol Nurs; 2023 Mar; 10(3):100191. PubMed ID: 36820235
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum to "Metastatic hepatoid carcinoma of ovarian origin - A case report from Northern Pakistan" [Gynecol. Oncol. Rep. 21 (2017) 24-27].
Mahmood H; Fatima H; Faheem M
Gynecol Oncol Rep; 2017 Nov; 22():117. PubMed ID: 29296656
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum to "Assessing pripherally inserted central catheter tip location in multiple postures: A case report" [Asia-Pacific J Oncol Nurs 10 (2023) 100238].
He X; Wu S; Zhang F; Ge W; Wu D; Chen M; Li K; Ren X
Asia Pac J Oncol Nurs; 2024 May; 11(5):100434. PubMed ID: 38770180
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum to "Feasibility and acceptability of motivational interviewing to promote colorectal cancer screening among average risk Chinese older adults" [Asia-Pacific J Oncol Nurs 10 (2023) 100315].
Chan DNS; Choi KC
Asia Pac J Oncol Nurs; 2024 Mar; 11(3):100369. PubMed ID: 38440156
[TBL] [Abstract][Full Text] [Related]
12. Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis.
Amer KM; Munn M; Congiusta D; Abraham JA; Basu Mallick A
J Orthop Res; 2020 Feb; 38(2):311-319. PubMed ID: 31498474
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum to "Evaluation of a whole process management model based on an information system for cancer patients with pain: A prospective nonrandomized controlled study" [Asia-Pacific J Oncol Nurs 9 (2022) 88-96].
Yang H; Yu W; Zhang H; Heng F; Ma X; Li N; Wang Z; Hou X; Guo R; Lu Y
Asia Pac J Oncol Nurs; 2023 Mar; 10(3):100192. PubMed ID: 36876163
[TBL] [Abstract][Full Text] [Related]
14. Dedifferentiated chondrosarcoma mimicking a giant cell tumor. Is this low grade dedifferentiated chondrosarcoma?
Knösel T; Werner M; Jung A; Kirchner T; Dürr HR
Pathol Res Pract; 2014 Mar; 210(3):194-7. PubMed ID: 24405942
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum to "Adjuvant and first line chemotherapy use for endometrial cancer" [Gynecol. Oncol. Rep. 41 (2022) 101002].
Knisely A; Huang Y; Li Y; Prabhu VS; Wright JD
Gynecol Oncol Rep; 2023 Apr; 46():101112. PubMed ID: 37082519
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum to "Investigating nurses' acceptance of patients' bring your own device implementation in a clinical setting: A pilot study" [Asia-Pacific J Oncol Nurs 10 (2023) 100195].
Chien SC; Chen CY; Chien CH; Iqbal U; Yang HC; Hsueh HC; Weng SF; Jian WS
Asia Pac J Oncol Nurs; 2024 May; 11(5):100437. PubMed ID: 38812673
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum to "Co-existent abdominoperitoneal tuberculosis with endometrial cancer: A diagnostic and surgical challenge" [Gynecol. Oncol. Rep. 37 (2021) 100848].
Ashraf M; Goh WA; Tan EMX; Nadarajah R
Gynecol Oncol Rep; 2021 Nov; 38():100861. PubMed ID: 34977315
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272].
López Torrecilla J; Hervás A; Zapatero A; Gómez Caamaño A; Macías V; Herruzo I; Maldonado X; Gómez Iturriaga A; Casas F; González San Segundo C
Rep Pract Oncol Radiother; 2016; 21(1):90-2. PubMed ID: 26900365
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum to "Two compound techniques for total body irradiation" [Tech. Innov. Patient Support Radiat. Oncol. 21 (2022) 1-7].
Hansen AT; Rose HK; Yates ES; Hansen J; Petersen JBB
Tech Innov Patient Support Radiat Oncol; 2023 Mar; 25():100199. PubMed ID: 36659910
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum to "Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation" [Gynecol. Oncol. Rep. 22 (2017) 9-12].
Martin M; Grisham RN; Turashvili G; Halpenny DF; Aghajanian CA; Makker V
Gynecol Oncol Rep; 2017 Nov; 22():118. PubMed ID: 29296657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
